Transcatheter therapies in structural heart disease have evolved tremendously over the past 15 years. Since the introduction of the first balloon-expandable valves for stenotic lesions with implantation in the pulmonic position in 2000, treatment for valvular heart disease in the outflow position has become more refined, with newer-generation devices, alternative techniques, and novel access approaches. Recent efforts into the inflow position and regurgitant lesions, with transcatheter repair and replacement technologies, have expanded our potential to treat a broader, more heterogeneous patient population. The evolution of multimodality imaging has paralleled these developments. Three-and 4-dimensional 
This can result in exercise intolerance, heart failure, arrhythmias, and risk for sudden cardiac death (8) . RV enlargement may also lead to adverse RV/LV interaction, resulting in dysfunction (9) . Timely consideration of pulmonary valve replacement, together with other interventions as needed for any potential abnormalities of RV afterload (e.g., central or peripheral pulmonary artery [PA] stenosis, pulmonary arterial hypertension), is integral in optimizing long-term outcomes (10) .
INFLOW VALVES. Native mitral regurgitation (MR) or MR after mitral valve replacement or mitral valve repair is not uncommon. The incidence of prosthetic regurgitation depends on the type of prosthesis either bioprosthetic or mechanical. Like aortic PVLs, the true incidence of mitral PVLs is unknown; however, rates as high as 32% have been reported (11) Additionally, patients who develop progressive TR late after left-sided valve surgery represent a particular challenge (14) . In this subgroup, despite medical management, surgical correction is associated with a higher risk of morbidity and mortality as a result of the presence of variable degrees of RV dysfunction, pulmonary vascular disease, and right heart failure. The pre-operative condition of the RV and the severity of secondary renal and hepatic impairment are predictors of survival.
IMAGING OF VALVULAR REGURGITATION
Echocardiography is the gold-standard imaging modality for the evaluation of regurgitant valvular and PVL lesions (15, 16) . Severity is assessed on the basis of qualitative and quantitative measures. Qualitative measurements include the area of regurgitant color flow, the density and contour of the regurgitant signal, and other indexes such as the time velocity In a recent meta-analysis that included 12 clinical studies and totaled 362 patients, overall technical and procedural success rates were 86.5% and 76.5%, respectively (54) . Thirty percent of PVLs were in the 
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